Funder
GlaxoSmithKline (China) R&D Company Limited
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference27 articles.
1. Nglazi MD, Joubert JD, Stein DJ, et al. Epidemiology of major depressive disorder in South Africa (1997-2015): a systematic review protocol. BMJ Open. 2016;6:es011749.
2. Low W, Azmi S, Li Y, et al. Prevalence of major depressive disorder in China. Value Health. 2014;[Abstract:PMH9].
3. World Population Prospects: The 2017 Revision. Available from
https://esa.un.org/unpd/wpp/DataQuery/
. Accessed 02 May 2018.
4. Lepine BA, Moreno RA, Campos RN, et al. Treatment-resistant depression increases health costs and resource utilization. Rev Bras Psiquiatr. 2012;34:379–88.
5. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献